Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Seattle Children's Hospital Molecular Genetics Laboratory, |
RCV001848620 | SCV002106344 | uncertain significance | Type 2 diabetes mellitus | 2019-09-05 | criteria provided, single submitter | clinical testing | This variant has not been observed previously in our laboratory and is absent from both clinical and general population databases. This is a moderately conserved nucleotide position across species. Most computational tools predict this change is damaging. |
Ambry Genetics | RCV003264115 | SCV003944715 | uncertain significance | Inborn genetic diseases | 2023-03-31 | criteria provided, single submitter | clinical testing | The c.392C>T (p.A131V) alteration is located in exon 4 (coding exon 4) of the CEL gene. This alteration results from a C to T substitution at nucleotide position 392, causing the alanine (A) at amino acid position 131 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |